PerspectiveRegulatory Science

What evidence do we need for biomarker qualification?

See allHide authors and affiliations

Science Translational Medicine  22 Nov 2017:
Vol. 9, Issue 417, eaal4599
DOI: 10.1126/scitranslmed.aal4599

You are currently viewing the abstract.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Abstract

Biomarkers can facilitate all aspects of the drug development process. However, biomarker qualification—the use of a biomarker that is accepted by the U.S. Food and Drug Administration—needs a clear, predictable process. We describe a multistakeholder effort including government, industry, and academia that proposes a framework for defining the amount of evidence needed for biomarker qualification. This framework is intended for broad applications across multiple biomarker categories and uses.

View Full Text